Eli Lilly will acquire biotech company Kelonia Therapeutics in a deal worth up to $7 billion, the company said Monday. Lilly will pay $3.25 billion upfront, and the remaining payments are contingent upon clinical, regulatory and commercial milestones, it said.
Story intelligence
0 claims checkedWhat we know about the US capture of Iranian vessel near Hormuz What we know about the US capture of Iranian vessel near Hormuz US forces have released video appearing to show the capture of an…
In the age of AI, building solid interpersonal relationships at work has never been more important. One of the best ways to form those connections is through casual conversation, or small talk. Learn…
Bulgaria: Pro-Russia Rumen Radev wins election April 20, 2026Progressive Bulgaria, the party led by former President Rumen Radev, won a landslide victory in general elections in Bulgaria, official…
Alex Bores, a Democratic House candidate in New York and a top target of AI super PACs, is rolling out a plan to create an "AI dividend" in response to potential large-scale job displacement from…
Saildrone on Monday unveiled Spectre, a 170-foot unmanned surface vessel the company says is optimized for anti-submarine warfare, far-flung surveillance and missile launches. Why it matters: The…
Atlanta, Boston, Chicago, Denver and Philadelphia are competing to host the 2028 Democratic National Convention, the party announced Monday. Why it matters: The city selected will become the center…
U.S. stock futures were down Monday morning as markets absorbed weekend events that made it clear the Iran war is not over. The price of Brent oil futures, which took a historic plunge on Friday are…
I was standing at a hotel coffee station last month, holding a tiny porcelain creamer shaped like a cow, when a stranger walked up next to me and said: "Hello." My brain went completely blank.